徐放性注射剤の世界市場レポート2020

• 英文タイトル：Global Sustained Release Injectables Sales Market Report 2020

• レポートコード：QY20ST-06028 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥560,000 (USD4,000)	▷ お問い合わせ
Multi User	￥840,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,120,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界の徐放性注射剤市場について種類別（ナルトレキソン、エクセナチド、エストラジオール、その他）、用途別（糖尿病、白血病、先端巨大症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・徐放性注射剤市場の概要 ・世界の主要地域別徐放性注射剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の徐放性注射剤市場規模2015-2026：種類別（ナルトレキソン、エクセナチド、エストラジオール、その他） ・世界の徐放性注射剤市場規模2015-2026：用途別（糖尿病、白血病、先端巨大症、その他） ・徐放性注射剤の北米市場規模2015-2020 ・徐放性注射剤のヨーロッパ市場規模2015-2020 ・徐放性注射剤の中国市場規模2015-2020 ・徐放性注射剤の日本市場規模2015-2020 ・徐放性注射剤の東南アジア市場規模2015-2020 ・徐放性注射剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・徐放性注射剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・徐放性注射剤の市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Sustained Release Injectables Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Sustained Release Injectables market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
It is a preparation with better therapeutic effect by delaying drug release rate from the formulation and reducing drug absorption rate into the body.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sustained Release Injectables market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Sustained Release Injectables industry.
Based on our recent survey, we have several different scenarios about the Sustained Release Injectables YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sustained Release Injectables will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Sustained Release Injectables market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Sustained Release Injectables market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Sustained Release Injectables market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Sustained Release Injectables market. The report also includes nautical information, where it shows Sustained Release Injectables market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Sustained Release Injectables market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Sustained Release Injectables market.
Geographical Analysis:
Based on region, the global Sustained Release Injectables market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Sustained Release Injectables market are
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Ascendis Pharma
Taiwan Liposome Company
Segment by Type
Naltrexone
Exenatide
Estradiol
Other
Segment by Application
Diabetes
Leukemia
Acromegaly
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Sustained Release Injectables market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Sustained Release Injectables market.
• The market share of the global Sustained Release Injectables market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Sustained Release Injectables market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Sustained Release Injectables market.

レポート目次

---

1 Sustained Release Injectables Market Overview
1.1 Sustained Release Injectables Product Scope
1.2 Sustained Release Injectables Segment by Type
1.2.1 Global Sustained Release Injectables Sales by Type (2020-2026)
1.2.2 Naltrexone
1.2.3 Exenatide
1.2.4 Estradiol
1.2.5 Other
1.3 Sustained Release Injectables Segment by Application
1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2020-2026)
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Other
1.4 Sustained Release Injectables Market Estimates and Forecasts (2015-2026)
1.4.1 Global Sustained Release Injectables Sales Growth Rate (2015-2026)
1.4.2 Global Sustained Release Injectables Revenue and Growth Rate (2015-2026)
1.4.3 Global Sustained Release Injectables Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
1.5.1 How the Covid-19 is Affecting the Sustained Release Injectables Industry
1.5.1.1 Sustained Release Injectables Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact

2 Sustained Release Injectables Estimate and Forecast by Region
2.1 Global Sustained Release Injectables Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2015-2020)
2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2015-2020)
2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Sustained Release Injectables Estimates and Projections (2015-2026)
2.4.2 Europe Sustained Release Injectables Estimates and Projections (2015-2026)
2.4.3 China Sustained Release Injectables Estimates and Projections (2015-2026)
2.4.4 Japan Sustained Release Injectables Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2015-2026)
2.4.6 India Sustained Release Injectables Estimates and Projections (2015-2026)
3 Global Sustained Release Injectables Competition Landscape by Players
3.1 Global Top Sustained Release Injectables Players by Sales (2015-2020)
3.2 Global Top Sustained Release Injectables Players by Revenue (2015-2020)
3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2019)
3.4 Global Sustained Release Injectables Average Price by Company (2015-2020)
3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Sustained Release Injectables Players (Opinion Leaders)
4 Global Sustained Release Injectables Market Size by Type
4.1 Global Sustained Release Injectables Historic Market Review by Type (2015-2020)
4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2015-2020)
4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2015-2020)
4.1.3 Global Sustained Release Injectables Price by Type (2014-2020)
4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2021-2026)
4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2021-2026)
4.2.3 Global Sustained Release Injectables Price Forecast by Type (2021-2026)
5 Global Sustained Release Injectables Market Size by Application
5.1 Global Sustained Release Injectables Historic Market Review by Application (2015-2020)
5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2015-2020)
5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2015-2020)
5.1.3 Global Sustained Release Injectables Price by Application (2015-2020)
5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2021-2026)
5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2021-2026)
5.2.3 Global Sustained Release Injectables Price Forecast by Application (2021-2026)

3 North America Sustained Release Injectables Market Facts & Figures
3.2 North America Sustained Release Injectables Sales Market Share by Company (2015-2020)
3.3 North America Sustained Release Injectables Sales Market Share by Type (2015-2020)
3.4 North America Sustained Release Injectables Sales Market Share by Application (2015-2020)

4 Europe Sustained Release Injectables Market Facts & Figures
4.2 Europe Sustained Release Injectables Sales Market Share by Company (2015-2020)
4.3 Europe Sustained Release Injectables Sales Market Share by Type (2015-2020)
4.4 Europe Sustained Release Injectables Sales Market Share by Application (2015-2020)

5 China Sustained Release Injectables Market Facts & Figures
5.2 China Sustained Release Injectables Sales Market Share by Company (2015-2020)
5.3 China Sustained Release Injectables Sales Market Share by Type (2015-2020)
5.4 China Sustained Release Injectables Sales Market Share by Application (2015-2020)

6 Japan Sustained Release Injectables Market Facts & Figures
6.2 Japan Sustained Release Injectables Sales Market Share by Company (2015-2020)
6.3 Japan Sustained Release Injectables Sales Market Share by Type (2015-2020)
6.4 Japan Sustained Release Injectables Sales Market Share by Application (2015-2020)

7 Southeast Asia Sustained Release Injectables Market Facts & Figures
7.2 Southeast Asia Sustained Release Injectables Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Sustained Release Injectables Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Sustained Release Injectables Sales Market Share by Application (2015-2020)

8 India Sustained Release Injectables Market Facts & Figures
8.2 India Sustained Release Injectables Sales Market Share by Company (2015-2020)
8.3 India Sustained Release Injectables Sales Market Share by Type (2015-2020)
8.4 India Sustained Release Injectables Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Sustained Release Injectables Business
12.1 AstraZeneca
12.1.1 AstraZeneca Sustained Release Injectables Corporation Information
12.1.2 AstraZeneca Sustained Release Injectables Business Overview and Total Revenue
12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Sustained Release Injectables Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Sustained Release Injectables Corporation Information
12.2.2 Eli Lilly Sustained Release Injectables Business Overview and Total Revenue
12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Sustained Release Injectables Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Sanofi
12.3.1 Sanofi Sustained Release Injectables Corporation Information
12.3.2 Sanofi Sustained Release Injectables Business Overview and Total Revenue
12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Sustained Release Injectables Products Offered
12.3.5 Sanofi Recent Development
12.4 Roche
12.4.1 Roche Sustained Release Injectables Corporation Information
12.4.2 Roche Sustained Release Injectables Business Overview and Total Revenue
12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche Sustained Release Injectables Products Offered
12.4.5 Roche Recent Development
12.5 Novartis
12.5.1 Novartis Sustained Release Injectables Corporation Information
12.5.2 Novartis Sustained Release Injectables Business Overview and Total Revenue
12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Sustained Release Injectables Products Offered
12.5.5 Novartis Recent Development
12.6 Aurobindo
12.6.1 Aurobindo Sustained Release Injectables Corporation Information
12.6.2 Aurobindo Sustained Release Injectables Business Overview and Total Revenue
12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Aurobindo Sustained Release Injectables Products Offered
12.6.5 Aurobindo Recent Development
12.7 Avadel
12.7.1 Avadel Sustained Release Injectables Corporation Information
12.7.2 Avadel Sustained Release Injectables Business Overview and Total Revenue
12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Avadel Sustained Release Injectables Products Offered
12.7.5 Avadel Recent Development
12.8 Biomarin
12.8.1 Biomarin Sustained Release Injectables Corporation Information
12.8.2 Biomarin Sustained Release Injectables Business Overview and Total Revenue
12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Biomarin Sustained Release Injectables Products Offered
12.8.5 Biomarin Recent Development
12.9 Camurus
12.9.1 Camurus Sustained Release Injectables Corporation Information
12.9.2 Camurus Sustained Release Injectables Business Overview and Total Revenue
12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Camurus Sustained Release Injectables Products Offered
12.9.5 Camurus Recent Development
12.10 Critical Pharmaceuticals
12.10.1 Critical Pharmaceuticals Sustained Release Injectables Corporation Information
12.10.2 Critical Pharmaceuticals Sustained Release Injectables Business Overview and Total Revenue
12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
12.10.5 Critical Pharmaceuticals Recent Development
12.11 Alkermes
12.11.1 Alkermes Sustained Release Injectables Corporation Information
12.11.2 Alkermes Sustained Release Injectables Business Overview and Total Revenue
12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Alkermes Sustained Release Injectables Products Offered
12.11.5 Alkermes Recent Development
12.12 Amylin
12.12.1 Amylin Sustained Release Injectables Corporation Information
12.12.2 Amylin Sustained Release Injectables Business Overview and Total Revenue
12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Amylin Sustained Release Injectables Products Offered
12.12.5 Amylin Recent Development
12.13 Ascendis Pharma
12.13.1 Ascendis Pharma Sustained Release Injectables Corporation Information
12.13.2 Ascendis Pharma Sustained Release Injectables Business Overview and Total Revenue
12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
12.13.5 Ascendis Pharma Recent Development
12.14 Taiwan Liposome Company
12.14.1 Taiwan Liposome Company Sustained Release Injectables Corporation Information
12.14.2 Taiwan Liposome Company Sustained Release Injectables Business Overview and Total Revenue
12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis
13.1 Sustained Release Injectables Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sustained Release Injectables
13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sustained Release Injectables Distributors List
14.3 Sustained Release Injectables Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Sustained Release Injectables Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Sustained Release Injectables Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Sustained Release Injectables Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Sustained Release Injectables Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Sustained Release Injectables Players to Combat Covid-19 Impact
Table 8. Global Market Sustained Release Injectables Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Sustained Release Injectables Sales (K Units) by Region (2015-2020)
Table 10. Global Sustained Release Injectables Sales Market Share by Region (2015-2020)
Table 11. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Sustained Release Injectables Revenue Share by Region (2015-2020)
Table 13. Global Sustained Release Injectables Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Sustained Release Injectables Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Sustained Release Injectables Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Sustained Release Injectables Revenue Share Forecast by Region (2021-2026)
Table 17. Global Sustained Release Injectables (K Units) of Key Companies (2015-2020)
Table 18. Global Sustained Release Injectables Sales Share by Company (2015-2020)
Table 19. Global Sustained Release Injectables Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Sustained Release Injectables Revenue Share by Company (2015-2020)
Table 21. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2019)
Table 22. Global Sustained Release Injectables Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served
Table 24. Manufacturers Sustained Release Injectables Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Sustained Release Injectables Players
Table 27. Global Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 28. Global Sustained Release Injectables Sales Share by Type (2015-2020)
Table 29. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Sustained Release Injectables Price (K Units) by Type (2015-2020)
Table 31. Global Sustained Release Injectables Sales Share by Type (2021-2026)
Table 32. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Sustained Release Injectables Revenue Share by Type (2021-2026)
Table 34. Global Sustained Release Injectables Price (K Units) by Type (2021-2026)
Table 35. Global Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 36. Global Sustained Release Injectables Sales Share by Application (2015-2020)
Table 37. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Sustained Release Injectables Price (K Units) by Application (2015-2020)
Table 39. Global Sustained Release Injectables Sales (K Units) by Application (2021-2026)
Table 40. Global Sustained Release Injectables Sales Share by Application (2021-2026)
Table 41. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Sustained Release Injectables Revenue Share by Application (2021-2026)
Table 43. Global Sustained Release Injectables Price (K Units) by Application (2021-2026)
Table 44. United States Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 45. United States Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 46. United States Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 47. United States Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 48. United States Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 49. United States Sustained Release Injectables Sales Market Share by Application (2015-2020)
Table 50. Europe Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 51. Europe Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 52. Europe Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 53. Europe Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 54. Europe Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 55. Europe Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 56. China Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 57. China Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 58. China Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 59. China Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 60. China Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 61. China Sustained Release Injectables Sales Market Share by Application (2015-2020)
Table 62. Japan Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 63. Japan Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 64. Japan Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 65. Japan Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 66. Japan Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 67. Japan Sustained Release Injectables Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2015-2020)
Table 74. India Sustained Release Injectables Sales (K Units) by Company (2015-2020)
Table 75. India Sustained Release Injectables Sales Market Share by Company (2015-2020)
Table 76. India Sustained Release Injectables Sales (K Units) by Type (2015-2020)
Table 77. India Sustained Release Injectables Sales Market Share by Type (2015-2020)
Table 78. India Sustained Release Injectables Sales (K Units) by Application (2015-2020)
Table 79. India Sustained Release Injectables Sales Market Share by Application (2015-2020)
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AstraZeneca Sustained Release Injectables Product
Table 84. AstraZeneca Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly Sustained Release Injectables Product
Table 89. Eli Lilly Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi Sustained Release Injectables Product
Table 94. Sanofi Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Business Overview
Table 97. Roche Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Roche Sustained Release Injectables Product
Table 99. Roche Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis Sustained Release Injectables Product
Table 104. Novartis Recent Development
Table 105. Aurobindo Corporation Information
Table 106. Aurobindo Description and Business Overview
Table 107. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Aurobindo Sustained Release Injectables Product
Table 109. Aurobindo Recent Development
Table 110. Avadel Corporation Information
Table 111. Avadel Description and Business Overview
Table 112. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Avadel Sustained Release Injectables Product
Table 114. Avadel Recent Development
Table 115. Biomarin Corporation Information
Table 116. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Biomarin Description and Business Overview
Table 118. Biomarin Sustained Release Injectables Product
Table 119. Biomarin Recent Development
Table 120. Camurus Corporation Information
Table 121. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Camurus Description and Business Overview
Table 123. Camurus Sustained Release Injectables Product
Table 124. Camurus Recent Development
Table 125. Critical Pharmaceuticals Corporation Information
Table 126. Critical Pharmaceuticals Description and Business Overview
Table 127. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Critical Pharmaceuticals Sustained Release Injectables Product
Table 129. Critical Pharmaceuticals Recent Development
Table 130. Alkermes Corporation Information
Table 131. Alkermes Description and Business Overview
Table 132. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Alkermes Sustained Release Injectables Product
Table 134. Alkermes Recent Development
Table 135. Amylin Corporation Information
Table 136. Amylin Description and Business Overview
Table 137. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Amylin Sustained Release Injectables Product
Table 139. Amylin Recent Development
Table 140. Ascendis Pharma Corporation Information
Table 141. Ascendis Pharma Description and Business Overview
Table 142. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Ascendis Pharma Sustained Release Injectables Product
Table 144. Ascendis Pharma Recent Development
Table . Taiwan Liposome Company Corporation Information
Table . Taiwan Liposome Company Description and Business Overview
Table . Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Taiwan Liposome Company Sustained Release Injectables Product
Table . Taiwan Liposome Company Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Sustained Release Injectables Distributors List
Table 153. Sustained Release Injectables Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Injectables Product Picture
Figure 2. Global Sustained Release Injectables Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sustained Release Injectables Market Share by Application in 2020 & 2026
Figure 6. Diabetes Examples
Figure 7. Leukemia Examples
Figure 8. Acromegaly Examples
Figure 9. Other Examples
Figure 10. Global Sustained Release Injectables Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Sustained Release Injectables Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Sustained Release Injectables Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Sustained Release Injectables Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Sustained Release Injectables Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Sustained Release Injectables Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Sustained Release Injectables Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Sustained Release Injectables Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Sustained Release Injectables Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Sustained Release Injectables Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Sustained Release Injectables Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Sustained Release Injectables Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Sustained Release Injectables Players Market Share by Revenue in Sustained Release Injectables 2015 & 2019
Figure 28. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Sustained Release Injectables Revenue Share by Type (2015-2020)
Figure 30. Global Sustained Release Injectables Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Sustained Release Injectables Revenue Share by Application (2015-2020)
Figure 32. Global Sustained Release Injectables Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Sustained Release Injectables Sales Market Share by Type in 2019
Figure 34. United States Sustained Release Injectables Sales Market Share by Type in 2019
Figure 35. Europe Sustained Release Injectables Sales Market Share by Company in 2019
Figure 36. Europe Sustained Release Injectables Sales Market Share by Type in 2019
Figure 37. Europe Sustained Release Injectables Sales Market Share by Application in 2019
Figure 38. China Sustained Release Injectables Sales Market Share by Company in 2019
Figure 39. China Sustained Release Injectables Sales Market Share by Type in 2019
Figure 40. China Sustained Release Injectables Sales Market Share by Application in 2019
Figure 41. Japan Sustained Release Injectables Sales Market Share by Company in 2019
Figure 42. Japan Sustained Release Injectables Sales Market Share by Type in 2019
Figure 43. Japan Sustained Release Injectables Sales Market Share by Application in 2019
Figure 44. Southeast Asia Sustained Release Injectables Sales Market Share by Company in 2019
Figure 45. Southeast Asia Sustained Release Injectables Sales Market Share by Type in 2019
Figure 46. Southeast Asia Sustained Release Injectables Sales Market Share by Application in 2019
Figure 47. India Sustained Release Injectables Sales Market Share by Company in 2019
Figure 48. India Sustained Release Injectables Sales Market Share by Type in 2019
Figure 49. India Sustained Release Injectables Sales Market Share by Application in 2019
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Avadel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Biomarin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Camurus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Critical Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Alkermes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Amylin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Ascendis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Taiwan Liposome Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Sustained Release Injectables
Figure 66. Manufacturing Process Analysis of Sustained Release Injectables
Figure 67. Sustained Release Injectables Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---